Immunotherapy Nusantara by Terawan: Reactivate Your Body’s Natural Immune Power
The human body contains two main types of blood cells: red blood cells and white blood cells. White blood cells act as the body’s first line of defense, protecting you from viruses, bacteria, and even tumor cells. They also produce antibodies that help the body fight inflammation.
Through Immunotherapy Nusantara, Dr. Terawan introduces a new approach to reactivating the body’s natural immune strength. This immunotherapy is personalized, as it uses dendritic cells derived from the patient’s own blood.
The therapy aims to enhance the body’s immunity and “train” the immune system to respond more intelligently to various health conditions—from cancer, infections, and autoimmune diseases to degenerative disorders.
The process of immunotherapy involves a special white blood cell called a monocyte.
These cells are collected from the patient’s blood and then cultured in a laboratory. Using a specific medium, the monocytes transform into dendritic cells. These cells are then injected back into the patient’s body.
Dendritic cells function to stimulate and regulate the immune response. Since the therapy uses autologous cells (derived from the patient), it is considered very safe.
Benefits of immunotherapy:
- Strengthens the body’s immunity against various diseases.
- Helps reduce excessive immune responses, such as in autoimmune conditions.
- Supports long-term immune protection.
Scientific evidence on dendritic cells
Autologous dendritic cells—cells that come from the patient—have been widely studied and proven safe for therapeutic use.
Multiple studies demonstrate their potential and safety across various health conditions, including COVID-19 vaccines, Hepatitis B therapy, HSV (herpes) infections, HIV infections, glioblastoma (brain cancer), kidney cancer, pancreatic cancer, type 1 diabetes, rheumatoid arthritis, and multiple sclerosis.
These studies highlight that dendritic cells can direct a more targeted immune response while maintaining safety due to their autologous nature.
Immunotherapy procedure
Dendritic-cell–based immunotherapy is carried out in two visits:
1. First visit: blood collection
Approximately 40 cc of blood is drawn from the patient. This sample is processed in the laboratory for about seven days.
During this time, white blood cells are separated from red blood cells.
Monocytes—special white blood cells—are cultured using a specific medium until they develop into dendritic cells.
2. Second visit: immunotherapy injection
On day seven, the mature dendritic cells are prepared and diluted with an infusion solution.
Immunotherapy is administered subcutaneously (under the skin) at approximately one cc.
Necessary: The injection schedule cannot be rescheduled because the cells remain optimal only within a specific time window.
How to get immunotherapy
- Book an appointment at GWS Medika Clinic by contacting Customer Care at 0881 1677 889. Our team will schedule your blood collection visit.
- Visit GWS Medika Clinic for the 40 cc blood draw.
- Return to the clinic on day seven for the immunotherapy injection.
After receiving the injection, every immunotherapy patient will receive free autologous plasma.
This plasma is rich in growth factors that help smooth the skin and support hair growth.
How to use autologous plasma:
- For external use only. Apply to the skin or scalp.
- Use only by the patient; do not share it with anyone else.
Potential risks
This procedure is considered safe because it uses the patient’s own cells. However, mild side effects may occur:
- After blood collection: pain, swelling, redness, or bruising at the injection site, which typically resolves on its own.
- Rarely: patients may experience mild fever or a minor allergic reaction after the immunotherapy injection.
Frequently Asked Questions (FAQ)
1. At what age can this therapy be given?
Immunotherapy can be administered starting from age six. To date, there is no maximum age limit. However, it is not recommended for pregnant women.
2. Does the therapy need to be repeated?
The frequency depends on the patient’s health condition.
To maintain optimal immune performance, therapy can be repeated every three months or once a year.
For patients with certain conditions, such as autoimmune diseases or cancer, doctors may recommend monthly sessions for three consecutive months.
3. Is this therapy safe for patients with diabetes or chronic illnesses?
Yes. This therapy can be given to patients with chronic conditions, including diabetes, to help reduce inflammation and support immune function.
***
Are you the right candidate for this therapy? Consult with our doctors today!
